# Safety of Anal Curcumin

> **NCT06626230** · PHASE1 · RECRUITING · sponsor: **Lisa Flowers** · enrollment: 48 (estimated)

## Conditions studied

- Anal High Grade Squamous Intraepithelial Lesion

## Interventions

- **DRUG:** Curcuminoid Capsules

## Key facts

- **NCT ID:** NCT06626230
- **Lead sponsor:** Lisa Flowers
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-17
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06626230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06626230, "Safety of Anal Curcumin". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06626230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*